Definium Therapeutics, Inc. (DFTX)

Definium Therapeutics, Inc. (DFTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $4.4B; returns 1 day -0.9%, 1 week +11.1%.

Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), trading under the Nasdaq ticker DFTX since January 15, 2026, is a clinical-stage biopharmaceutical company headquartered in New York.

Groups DFTX belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Biopharmaceutical
• Neuroscience
• CNS Disorders
• Mental Health Solutions
• Neurological Disorders
• Talk Therapy and Psychiatry
• Clinical Stage
• Pharmaceuticals

DFTX financial model: income statement, cash flow and balance sheet